A case of amoxicillin clavulanate drug induced liver injury

Amoxicillin clavulanate (Augmentin) is one of the most commonly used antibiotics in New Zealand (NZ). There are a number of known adverse effects of this drug, affecting the cutaneous, gastrointestinal, hepatic, and haematologic systems. Hepatic adverse effects, although rare (17 cases per 100,000 p...

Full description

Saved in:
Bibliographic Details
Published in:New Zealand medical student journal 2022-06 (34), p.10-11
Main Author: Heaven, Chelsea
Format: Article
Language:English
Subjects:
Amoxicillin
Diseases
Drugs
Hepatitis
Hepatotoxicology
Jaundice
Liver
Patients
Prevention
Side effects
Treatment
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 11
container_issue 34
container_start_page 10
container_title New Zealand medical student journal
container_volume
creator Heaven, Chelsea
description Amoxicillin clavulanate (Augmentin) is one of the most commonly used antibiotics in New Zealand (NZ). There are a number of known adverse effects of this drug, affecting the cutaneous, gastrointestinal, hepatic, and haematologic systems. Hepatic adverse effects, although rare (17 cases per 100,000 patients treated with amoxicillin clavulanate), include drug induced liver injury (DILI). This case of DILI secondary to amoxicillin clavulanate after admission with choledocholithiasis highlights the importance of recognising and treating rare but severe medication adverse effects.
doi_str_mv 10.57129/IISC8583
format article
fullrecord <record><control><sourceid>rmit_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_cae05a97065a4ed9a9d4576927fa3a94</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><informt_id>10.3316/informit.T2024111900000391503981044</informt_id><doaj_id>oai_doaj_org_article_cae05a97065a4ed9a9d4576927fa3a94</doaj_id><sourcerecordid>10.3316/informit.T2024111900000391503981044</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3393-598605bd925c97a948c7378319c204e23104337eec11b94afa60a5d5603d15533</originalsourceid><addsrcrecordid>eNqtkDFPHDEQhVcokYKAIv9gJSqKS2yPvd4RFToFchISBaS2BtsLPvnWyN5DkF-P7w5IGjqmmbHn-X3Wa5rvnP1Qmgv8uVhcz3vVw16zz7nGGSjUX_6bvzVHpSwZY1x3oIXcb07PWkvFt2loaZWegg0xhrG1kR7XkUaafOvy-q4No1tb79oYHn2up-U6Px82XweKxR-99oPmz_mvm_nv2eXVxWJ-djmzAAgzhX3H1K1DoSxqQtlbDboHjlYw6QVwJgG095bzW5Q0UMdIOdUxcFwpgINmsfN1iZbmIYcV5WeTKJjtRcp3hvIUbPTGkmeKULNOkfQOCZ1UukOhB4KKrl4nOy-bUynZD-9-nJltiOYtxKo93mnHOP41NQH_VDsicsVAip6JHnRVmZ0qr8JkbIrR2ymksSxpKqZ4yva-Ph7Sdr_5rEthQwPg3b_FJJiQnHNkm4ItA_sajfwsws3HhBePBawI</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A case of amoxicillin clavulanate drug induced liver injury</title><source>Directory of Open Access Journals</source><creator>Heaven, Chelsea</creator><creatorcontrib>Heaven, Chelsea</creatorcontrib><description>Amoxicillin clavulanate (Augmentin) is one of the most commonly used antibiotics in New Zealand (NZ). There are a number of known adverse effects of this drug, affecting the cutaneous, gastrointestinal, hepatic, and haematologic systems. Hepatic adverse effects, although rare (17 cases per 100,000 patients treated with amoxicillin clavulanate), include drug induced liver injury (DILI). This case of DILI secondary to amoxicillin clavulanate after admission with choledocholithiasis highlights the importance of recognising and treating rare but severe medication adverse effects.</description><identifier>ISSN: 1179-3597</identifier><identifier>ISSN: 1176-5178</identifier><identifier>EISSN: 1179-3597</identifier><identifier>DOI: 10.57129/IISC8583</identifier><language>eng</language><publisher>New Zealand: New Zealand Medical Student Journal</publisher><subject>Amoxicillin ; Diseases ; Drugs ; Hepatitis ; Hepatotoxicology ; Jaundice ; Liver ; Patients ; Prevention ; Side effects ; Treatment</subject><ispartof>New Zealand medical student journal, 2022-06 (34), p.10-11</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,2102,27924,27925</link.rule.ids><backlink>$$Uhttps://natlib-primo.hosted.exlibrisgroup.com/primo-explore/search?query=any,contains,999150342802837&amp;tab=innz&amp;search_scope=INNZ&amp;vid=NLNZ&amp;offset=0$$DView this record in NLNZ$$Hfree_for_read</backlink></links><search><creatorcontrib>Heaven, Chelsea</creatorcontrib><title>A case of amoxicillin clavulanate drug induced liver injury</title><title>New Zealand medical student journal</title><description>Amoxicillin clavulanate (Augmentin) is one of the most commonly used antibiotics in New Zealand (NZ). There are a number of known adverse effects of this drug, affecting the cutaneous, gastrointestinal, hepatic, and haematologic systems. Hepatic adverse effects, although rare (17 cases per 100,000 patients treated with amoxicillin clavulanate), include drug induced liver injury (DILI). This case of DILI secondary to amoxicillin clavulanate after admission with choledocholithiasis highlights the importance of recognising and treating rare but severe medication adverse effects.</description><subject>Amoxicillin</subject><subject>Diseases</subject><subject>Drugs</subject><subject>Hepatitis</subject><subject>Hepatotoxicology</subject><subject>Jaundice</subject><subject>Liver</subject><subject>Patients</subject><subject>Prevention</subject><subject>Side effects</subject><subject>Treatment</subject><issn>1179-3597</issn><issn>1176-5178</issn><issn>1179-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqtkDFPHDEQhVcokYKAIv9gJSqKS2yPvd4RFToFchISBaS2BtsLPvnWyN5DkF-P7w5IGjqmmbHn-X3Wa5rvnP1Qmgv8uVhcz3vVw16zz7nGGSjUX_6bvzVHpSwZY1x3oIXcb07PWkvFt2loaZWegg0xhrG1kR7XkUaafOvy-q4No1tb79oYHn2up-U6Px82XweKxR-99oPmz_mvm_nv2eXVxWJ-djmzAAgzhX3H1K1DoSxqQtlbDboHjlYw6QVwJgG095bzW5Q0UMdIOdUxcFwpgINmsfN1iZbmIYcV5WeTKJjtRcp3hvIUbPTGkmeKULNOkfQOCZ1UukOhB4KKrl4nOy-bUynZD-9-nJltiOYtxKo93mnHOP41NQH_VDsicsVAip6JHnRVmZ0qr8JkbIrR2ymksSxpKqZ4yva-Ph7Sdr_5rEthQwPg3b_FJJiQnHNkm4ItA_sajfwsws3HhBePBawI</recordid><startdate>202206</startdate><enddate>202206</enddate><creator>Heaven, Chelsea</creator><general>New Zealand Medical Student Journal</general><general>New Zealand Medical Student Journal Society</general><scope>GOM</scope><scope>LETOP</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>DOA</scope></search><sort><creationdate>202206</creationdate><title>A case of amoxicillin clavulanate drug induced liver injury</title><author>Heaven, Chelsea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3393-598605bd925c97a948c7378319c204e23104337eec11b94afa60a5d5603d15533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Amoxicillin</topic><topic>Diseases</topic><topic>Drugs</topic><topic>Hepatitis</topic><topic>Hepatotoxicology</topic><topic>Jaundice</topic><topic>Liver</topic><topic>Patients</topic><topic>Prevention</topic><topic>Side effects</topic><topic>Treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heaven, Chelsea</creatorcontrib><collection>Index New Zealand</collection><collection>Index New Zealand (Open Access)</collection><collection>CrossRef</collection><collection>Directory of Open Access Journals</collection><jtitle>New Zealand medical student journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heaven, Chelsea</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case of amoxicillin clavulanate drug induced liver injury</atitle><jtitle>New Zealand medical student journal</jtitle><date>2022-06</date><risdate>2022</risdate><issue>34</issue><spage>10</spage><epage>11</epage><pages>10-11</pages><issn>1179-3597</issn><issn>1176-5178</issn><eissn>1179-3597</eissn><abstract>Amoxicillin clavulanate (Augmentin) is one of the most commonly used antibiotics in New Zealand (NZ). There are a number of known adverse effects of this drug, affecting the cutaneous, gastrointestinal, hepatic, and haematologic systems. Hepatic adverse effects, although rare (17 cases per 100,000 patients treated with amoxicillin clavulanate), include drug induced liver injury (DILI). This case of DILI secondary to amoxicillin clavulanate after admission with choledocholithiasis highlights the importance of recognising and treating rare but severe medication adverse effects.</abstract><cop>New Zealand</cop><pub>New Zealand Medical Student Journal</pub><doi>10.57129/IISC8583</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1179-3597
ispartof New Zealand medical student journal, 2022-06 (34), p.10-11
issn 1179-3597
1176-5178
1179-3597
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_cae05a97065a4ed9a9d4576927fa3a94
source Directory of Open Access Journals
subjects Amoxicillin
Diseases
Drugs
Hepatitis
Hepatotoxicology
Jaundice
Liver
Patients
Prevention
Side effects
Treatment
title A case of amoxicillin clavulanate drug induced liver injury
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T20%3A04%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-rmit_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20of%20amoxicillin%20clavulanate%20drug%20induced%20liver%20injury&rft.jtitle=New%20Zealand%20medical%20student%20journal&rft.au=Heaven,%20Chelsea&rft.date=2022-06&rft.issue=34&rft.spage=10&rft.epage=11&rft.pages=10-11&rft.issn=1179-3597&rft.eissn=1179-3597&rft_id=info:doi/10.57129/IISC8583&rft_dat=%3Crmit_doaj_%3E10.3316/informit.T2024111900000391503981044%3C/rmit_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3393-598605bd925c97a948c7378319c204e23104337eec11b94afa60a5d5603d15533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_informt_id=10.3316/informit.T2024111900000391503981044&rfr_iscdi=true